Thomas Mark Partner MAIN OFFICE: New York Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, N.Y. 10019-6099, U.S.A. T 212-728-8667 F 212-728-9667

---

Thomas Mark is a partner in the Corporate & Financial Services Department of Willkie Farr & Gallagher LLP in New York. He specializes in mergers and acquisitions, securities offerings, private equity and general corporate and securities law.

Mr. Mark has advised on significant M&A, investment, and offering related matters for the following clients:

Mergers & Acquisitions:

• Telcordia Technologies, Providence Equity Partners and Warburg Pincus in the sale of Telcordia to Ericsson
  
  
• Level 3 Communications in its acquisitions of TelCove and Telverse Communications
  
  
• The joint venture of América Móvil and Teléfonos de Mexico in the venture’s proposed acquisition of Verizon’s interest in CANTV
  
  
• 3i in its acquisition of Hilite International
  
  
• Teléfonos de Mexico in the sale of its equity interest in MCI to Verizon
  
  
• Globe Specialty Metals in its sale of its Brazilian operations to Dow Corning and the establishment of a joint venture with Dow Corning at Globe’s West Virginia silicon metal facility
  
  
• Pharmion Corporation in connection with its acquisition of Cabrellis Pharmaceuticals; and its sale to Celgene Corporation
  
  
• Deutsche Bank as financial advisors in the merger of Ticketmaster and Live Nation
  
  
• Merrill Lynch as financial advisor to Dubai International Capital in connection with its investment in Och-Zifff Capital Management
  
  
• eToys in its acquisition of BabyUniverse
  
  
• Brookfield Asset Management in its cornerstone investment in General Growth Properties and its subsequent acquisition of an additional ownership interest in General Growth Properties
  
  
• Stiefel Laboratories in connection with its acquisitions of Connetics Corporation and Barrier Therapeutics; and in its sale to GlaxoSmithKline
  
  
• Warburg Pincus in connection with its acquisition of Scotsman Industries
  
  
• Big V Supermarkets in its sale to Wakefern Food
  
  
• Lehman Brothers in connection with its acquisition of Robeco Investment Management
  
  
• Adelphia Communications in connection with its bankruptcy restructuring
  
  
• Hampshire Group in connection with its sale of its Shane Hunter division

Securities Offerings:

• Pharmion Corporation in its initial public offering and subsequent follow-on offerings of common stock
  
  
• American Campus Communities in its initial public offering of common stock
  
  
• Clovis Oncology in its initial public offering of common stock
  
  
• Level 3 Communications in its various public offerings of common stock, senior notes and senior convertible notes
  
  
• Teva Pharmaceuticals in various public offerings of senior notes and senior convertible debentures
  
  
• Telcordia Technologies in its Rule 144A offering of senior notes
  
  
• Martin Marietta Materials in its public offering of senior notes
  
  
• The underwriters in Synageva’s public offering of its common stock
  
  
• The underwriters in Strategic Hotels’ public offering of its common stock
  
  
• The underwriters in Inspire Pharmaceutical’s various public offerings of common stock
  
  
• The underwriters in Lennar’s various public and Rule 144A offerings of senior notes
  
  
• The initial purchasers in LNR Property’s various Rule 144A offerings of senior convertible notes
  
  
• Converium in connection with its rights offering

Private Equity:

• Time Warner in its equity investment in Central European Media Enterprises
  
  
• Stiefel Laboratories in connection with Blackstone’s equity investment in Stiefel
  
  
• Warburg Pincus in connection with its equity investment in Cortview Capital
  
  
• Clovis Oncology in connection with multiple rounds of equity and debt financing by venture capital firms and Pfizer
  
  
• Soros Fund Management in connection with its equity investment in Salt Creek Hospitality
  
  
• Level 3 Communications in connection with Southeastern Asset Management’s senior convertible notes investment in Level 3